Compare SNBR & SXTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SNBR | SXTC |
|---|---|---|
| Founded | 1987 | 2005 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Home Furnishings | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 188.2M | 1.8M |
| IPO Year | 1998 | 2017 |
| Metric | SNBR | SXTC |
|---|---|---|
| Price | $3.34 | $1.78 |
| Analyst Decision | Hold | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $4.50 | N/A |
| AVG Volume (30 Days) | ★ 1.1M | 40.7K |
| Earning Date | 06-18-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,411,450,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $6.31 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.44 | $0.03 |
| 52 Week High | $13.94 | $6.98 |
| Indicator | SNBR | SXTC |
|---|---|---|
| Relative Strength Index (RSI) | 19.74 | 45.45 |
| Support Level | N/A | $1.40 |
| Resistance Level | $8.94 | $2.08 |
| Average True Range (ATR) | 0.71 | 0.17 |
| MACD | -0.27 | -0.08 |
| Stochastic Oscillator | 10.27 | 9.68 |
Sleep Number Corp. is a wellness technology company engaged in the design, manufacturing, marketing and distribution of sleep solutions. The Company generates revenue by marketing and selling its smart beds directly to new and existing customers through its vertically integrated, exclusive, direct-to-consumer retail touch points including Stores, Online, Phone, and Chat (Total Retail). The products offered by the company are Mattresses, Bedding, Pillows and Furniture.
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.